Stock Market News4 weeks Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here’s What You Should Know Zacks
The average of price targets set by Wall Street analysts indicates a potential upside of 29% in Harmony Biosciences (HRMY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
X